Earnings Feed
Start Free
|4Dec 19, 6:30 PM ET

Goldberg Andrew D. 4

4 · Tarsus Pharmaceuticals, Inc. · Filed Dec 19, 2023

Insider Transaction Report

Form 4
Period: 2023-12-15
Tarsus Pharmaceuticals, Inc.TARS
Goldberg Andrew D.
Director
Transactions
  • Purchase

    Common Stock

    2023-12-15$18.96/sh+1,000$18,960→ 3,000 total

Documents

1 file
  • 4
    wk-form4_1703028650.xmlPrimary

    FORM 4